GlobeNewswire Inc.··Immatics N.V.Immatics' Experimental Cancer Therapy Achieves Remission in Teen with Advanced Tumor
Immatics' PRAME-directed TCR therapy achieves deep remission in advanced pediatric cancer patient, validating engineered T-cell approach in solid tumors.
MRNAIMTXpediatric cancercell therapy